These nanobodies with circulation and tissue penetration characteristics optimized for imaging were labeled with 99mTc and 18F. The researchers demonstrated that macrophages in the tumor stroma were specifically targeted by the CD206 nanobodies 45, 46. The gene discussed is MRC1; the disease is neoplasm.